Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019
Akenroye et al1 discussed the use of corticosteroids and biologics in asthma during coronavirus disease 2019 (COVID-19) pandemic. COVID-19 began in the People's Republic of China and rapidly spread worldwide.2 Italy was the first European country involved in the pandemic and the first cluster occurring in Sou th Lombardy. The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), penetrates the host cells binding to the angiotensin-converting enzyme 2 (ACE2) receptors.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Giorgio Ciprandi, Amelia Licari, Gaetana Filippelli, Maria Angela Tosca, Gian Luigi Marseglia Tags: Correspondence Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Children | China Health | Coronavirus | Corticosteroid Therapy | COVID-19 | Italy Health | Pandemics | Respiratory Medicine | SARS